New WinR Initiative: Clinical Trials Incubator

WinR Launches New Initiative, Clinical Trials Incubator: A Pipeline to the Pipeline

The ASRS Women in Retina (WinR) Section is excited to announce a new extension of its Mentorship Program that aims to increase the participation of women retina specialists as principal investigators (PIs) in clinical trials: WinR Clinical Trials Incubator (CTI): A Pipeline to the Pipeline.

In recognition of the need to foster diversity and inclusion among PIs, study teams and patients in clinical research for the development of new therapies, this Mentorship Program aims to empower women retina specialists to step into such leadership roles, by offering peer-to-peer coaching as well as scientific guidance and operational support from clinical experts in industry.

WinR leadership will select one-two applicants per Program cycle. Industry clinical experts will partner with ASRS WinR leadership throughout the Program, sharing with the Mentee best practices in crucial aspects of clinical trial conduct, such as patient recruitment and retention, adherence to study protocol, and data integrity, among others. The industry partners may invite the Mentee selected by WinR to apply for the regular site selection process to potentially participate in future clinical trials, however no preferred participation in site selection will be granted.

Read more about the program in the Spring 2024 issue of Retina Times.

Applications for the 2023 CTI program are now closed. 

All ASRS members are invited to participate in a webinar series hosted by the Women in Retina (WinR) Section's Clinical Trials Incubator (CTI) . The series offers practical information on clinical trial participation. Register for upcoming sessions here or watch past sessions here.